Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...
11h
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...
Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback